Peng Shi
5 Papers
Peng Shi is an academic researcher. The author has contributed to research in topics: Monoamine neurotransmitter & Nicotinic agonist. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
Huiyang Liu,Xiaomei Zhang,Peng Shi,Jiyuan Yuan,Qiang Jia,Chao Pi,Linjin Xiong,Jinglin Chen,Jia Tang,Ruxu Yue,Zerong Liu,Hongping Shen,Ying Zuo,Yumeng Wei,Ling Zhao +14 more
TL;DR: In this paper , a review focused on the correlations between inflammation and depression as well as the crucial role of α7 nAChR in the cholinergic anti-inflammatory pathway.
The therapeutic value of bifidobacteria in cardiovascular disease
Chao Pi,Ying Zuo,Peng Shi,Linjin Xiong,Wei Ren,Peng Cao,Nan Zeng +6 more
- 30 Oct 2023
TL;DR: This review explores the direct and indirect effects of bifidobacteria on the development of CVD and highlights its potential therapeutic value in hypertension, atherosclerosis, myocardial infarction, and heart failure.
10
Anti atherosclerosis effect and mechanism of a novel curcumin analogue CACN136: regulating macrophage M1/M2 polarization and lipid metabolism
Qianjiao Zhao,Yueting Zhong,Zheng Li,Jia Tang,Chao Pi,Wenwu Zheng,Peng Shi,Ying Zuo,Jun Jiang,Yan Yang,Shifeng Chu,Yumeng Wei,Ling Zhao +12 more
2
Opportunities for the treatment of atherosclerosis: selectins.
Nong Li,Chao Pi,Siying Zhu,Xiumei Li,Liu Wang,Peng Shi,Ying Zuo,Wenwu Zheng,Jun Jiang,Yan Yang,Qiong Zhang,Lei Tao,Shifeng Chu,Yumeng Wei,Ling Zhao +14 more
Abstract: Despite the widespread availability of selectins for tumor therapy, their contribution to atherosclerosis has long been under-emphasized due to their "cofactor's" status and technological limitations. However, advances in immunohistology, glycomics, and related technologies require us to reassess their relationship. Thus, this review identifies pivotal translational opportunities from the intricate mechanisms and explores the clinical promise of selectins in the diagnosis and treatment of atherosclerosis based on the latest clinical research. This review provides insights into selectin-specific tracers and inhibitors, providing lessons for more precise diagnosis and treatment of patients with atherosclerosis.
Preparation and anti-colon cancer effect of a novel curcumin analogue (CA8): in vivo and in vitro evaluation
Jie Wen,Ling Zhao,Zhuohan Li,Chao Pi,Peng Shi,Hongru Yang,Ligang Chen,Xiaodong Wang,Furong Liu,Yumeng Wei,Ling Zhao +10 more
TL;DR: A novel curcumin analogue, CA8, exhibits enhanced water solubility, cytotoxicity, and anti-tumor effects in colon cancer cells, with improved bioavailability and safety profile, suggesting its potential as a new, effective treatment for colon cancer.